CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- 5 Insider Annual Insider Trading Report
- 4 Open-market sale SVP, Operations sold 60,000 shares at $29.14 ($1,748,400)
- 4/A Open-market sale Director sold 15,000 shares at an average $29.29 ($439,351)
- 4 Returned to the company Director returned 5,000 shares (to the company)
- 4 Open-market sale President sold 40,000 shares at $30.00 ($1,200,000)
- 4 Open-market sale President sold 135,000 shares at an average $28.98 ($3,912,585)
- 4 Returned to the company Director returned 15,000 shares (to the company)
- 4 Open-market sale President sold 160,000 shares at an average $29.73 ($4,757,060)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Option exercise CEO and Chairman acquired 20,000 shares (option exercise)
- 8-K Event Material agreement · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Material agreement · Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 4 Open-market buy Chief Financial Officer bought 1,000 shares at $20.00 ($20,000)
- 4 Open-market buy Sr Vice President, Operations bought 11,200 shares at $20.00 ($224,000)
- 4 Conversion Director acquired 3,866,016 shares (conversion)
- 4 Conversion CEO and Chairman acquired 70,680 shares (conversion)
Page 39 of 42 · 837 filings